Does paroxysmal nocturnal hemoglobinuria cause esophageal spasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Paroxysmal Nocturnal Hemoglobinuria Cause Esophageal Spasm?

Yes, paroxysmal nocturnal hemoglobinuria (PNH) is a recognized cause of esophageal spasm, though this is a symptom of the disease rather than a primary esophageal disorder.

Mechanism and Clinical Presentation

PNH causes esophageal spasm through a specific pathophysiologic mechanism related to intravascular hemolysis. When PNH red blood cells undergo complement-mediated destruction, free hemoglobin is released into the circulation. This free hemoglobin depletes circulating nitric oxide, which is essential for smooth muscle relaxation 1, 2, 3, 4. The resulting smooth muscle dystonia manifests as esophageal spasm, along with other smooth muscle-related symptoms including:

  • Abdominal pain
  • Erectile dysfunction
  • Fatigue

These symptoms are directly attributable to the hemolysis and nitric oxide depletion, not to a primary esophageal motility disorder 2, 3.

Diagnostic Considerations

When evaluating a patient with esophageal spasm, PNH should be considered in the differential diagnosis, particularly when:

  • Peripheral blood findings suggest hemolysis: Look for anemia, elevated LDH, elevated indirect bilirubin, low haptoglobin, and reticulocytosis
  • Associated symptoms are present: Hemoglobinuria (especially nocturnal or morning), fatigue disproportionate to anemia, abdominal pain, or thrombotic events
  • Cytopenias exist: Neutropenia or thrombocytopenia suggesting bone marrow involvement
  • Thrombosis occurs in unusual locations: Particularly intra-abdominal thrombosis including hepatic, portal, or mesenteric veins 5, 6

Flow cytometry screening for PNH should be performed in patients with unexplained hemolysis, particularly when combined with esophageal symptoms 7. Testing for CD55 and CD59 deficiency on red blood cells and granulocytes is the diagnostic standard.

Important Clinical Context

The esophageal spasm in PNH differs fundamentally from primary esophageal motility disorders like achalasia or diffuse esophageal spasm 8, 9. In PNH:

  • The spasm is secondary to systemic hemolysis and nitric oxide depletion
  • It typically improves with treatment of the underlying PNH
  • High-resolution manometry may show spastic contractions, but these are functional consequences of the hematologic disease rather than primary motility pathology

Treatment Implications

Complement inhibitors (eculizumab, ravulizumab) are the definitive treatment for PNH and have been shown to significantly reduce hemolysis and improve symptoms including esophageal spasm 1, 2, 4. These medications:

  • Reduce intravascular hemolysis by blocking terminal complement activation at C5
  • Restore nitric oxide availability by preventing free hemoglobin release
  • Improve smooth muscle function throughout the body
  • Significantly enhance quality of life measures including fatigue and pain scores

Treating esophageal spasm in PNH with standard approaches for primary motility disorders (calcium channel blockers, nitrates, or myotomy) would be inappropriate and ineffective, as these do not address the underlying complement-mediated hemolysis 1.

Key Clinical Pitfall

Do not mistake PNH-related esophageal spasm for a primary esophageal motility disorder. If a patient presents with esophageal spasm and any suggestion of hemolysis or unexplained cytopenias, screen for PNH with flow cytometry before pursuing invasive esophageal interventions. The presence of hemoglobinuria, particularly if nocturnal or associated with infections/vaccinations, should immediately raise suspicion for PNH 10, 1.

Related Questions

What are the most common symptoms of paroxysmal nocturnal hemoglobinuria?
Does a left ventricular assist device (LVAD) cause hemolysis?
How should a patient with paroxysmal nocturnal hemoglobinuria be managed, including complement inhibition therapy, vaccination, supportive care, anticoagulation, and monitoring?
How should hemolysis occurring during dialysis be managed?
In a patient with normal HbA1c, tightly regulated glucose (80‑95 mg/dL) even during stress and pregnancy, isolated glucosuria after a high‑carbohydrate meal, normal thyroid function, negative tests for paroxysmal nocturnal hemoglobinuria, Coombs, myoglobinuria, hematuria, pheochromocytoma, primary and secondary aldosteronism, and renal artery stenosis, and who meets criteria for stage 1 chronic kidney disease due to arteriosclerosis with an estimated glomerular filtration rate >100 mL/min/1.73 m², should complement‑C5 inhibition (eculizumab or ravulizumab) be initiated?
Which conditions does the VA (Veterans Affairs) and Medicare reimburse for ketamine (or esketamine) therapy?
What are the cardiac, joint, pulmonary, and skin manifestations of Sjögren’s syndrome?
How can I determine whether I have a coagulopathy?
What are the key components and questions to cover during an initial psychiatric visit for a patient with Alzheimer’s disease and reduced cognitive capacity?
What is the appropriate management for an acute abscess in hidradenitis suppurativa?
Is prescribing dextroamphetamine (extended‑release) 20 mg twice daily appropriate, and what monitoring guidelines should be followed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.